Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; General Administrative Procedures: Citizen Petitions; Petition for Reconsideration or Stay of Action; Advisory Opinions, 27502 [E6-7157]

Download as PDF 27502 Federal Register / Vol. 71, No. 91 / Thursday, May 11, 2006 / Notices cchase on PROD1PC60 with NOTICES announces the following subcommittee and committee meetings. Name: Science and Program Review Subcommittee (SPRS). Times and Dates: 6:30 p.m.–9:30 p.m., June 12, 2006. 8 a.m.–11:30 a.m., June 13, 2006. Place: Doubletree Hotel Atlanta, 3342 Peachtree Road, NE., Atlanta, GA 30326. Status: Open: 6:30 p.m.–7 p.m., June 12, 2006. Closed: 7 p.m.–9:30 p.m., June 12, 2006. Closed: 8 a.m.–10 a.m., June 13, 2006. Open: 10 a.m.–11:30 a.m., June 13, 2006. Purpose: The SPRS provides advice on the needs, structure, progress and performance of programs of the National Center for Injury Prevention and Control (NCIPC), as well as second-level scientific and programmatic review for applications for research grants, cooperative agreements, and training grants related to injury control and violence prevention, and recommends approval of projects that merit further consideration for funding support. The SPRS also advises on priorities for research to be supported by contracts, grants, and cooperative agreements and provides concept review of program proposals and announcements. Matters to be Discussed: The subcommittee will meet June 12–13 to provide a secondary review, discuss, and evaluate grant applications and cooperative agreements received in response to eight Request for Applications (RFAs) related to the following individual applications: #06001, Research Grants to Prevent Unintentional Injuries; #06002, Dissertation Grant Awards for Violence Injury Research in Minority Communities; #06003, Research Grants to Describe Traumatic Brain Injury Consequences; #06004, Grants for ViolenceRelated Injury Prevention Research; #06005, Research Grants for the Care of the Acutely Injured; #06006, Using Technology to Augment Effectiveness of Parenting Programs; #06007, Evaluation of CommunityBased Approaches to Increasing Seat Belt Use among Adolescents and Their Passengers; #06008, Urban Partnership Academic Centers of Excellence. This portion of the meeting (7 p.m.–9:30 p.m., June 12, 2006, and 8 a.m.– 10 a.m., June 13, 2006) will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5, U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Agenda items are subject to change as priorities dictate. Name: Advisory Committee for Injury Prevention and Control. Times and Dates: 1 p.m.–5:30 p.m., June 13, 2006. 8:30 a.m.–12 p.m., June 14, 2006. Place: Doubletree Hotel Atlanta, 3342 Peachtree Road, NE., Atlanta, GA 30326. Status: Closed: 1 p.m.–1:45 p.m., June 13, 2006. Open: 1:45 p.m.–5:30 p.m., June 13, 2006. Open: 8:30 a.m.–12 p.m., June 14, 2006. Purpose: The committee advises and makes recommendations to the Secretary, Department of Health and Human Services, the Director, CDC, and the Director, NCIPC, regarding feasible goals for the prevention and control of injury. The committee makes recommendations regarding policies, VerDate Aug<31>2005 16:29 May 10, 2006 Jkt 208001 strategies, objectives, and priorities, and reviews progress toward injury prevention and control. Matters to be Discussed: From 1 p.m.–1:45 p.m., June 13, 2006 the full committee will vote on the results of secondary review. This portion of the meeting will be closed to the public in accordance with provisions set forth in section 552(b)(4) and (6), title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Following the closed session, the meeting will open to the public. Agenda items are subject to change as priorities dictate. For Further Information Contact: Ms. Louise Galaska, Executive Secretary, ACIPC, NCIPC, CDC, 4770 Buford Highway, NE., M/ S K02, Atlanta, Georgia 30341–3724, telephone (770) 488–4694. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: May 5, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–7209 Filed 5–10–06; 8:45 am] (71 FR 7052), the agency announced that the proposed information collection had been submitted to OMB for review and clearance under 44 U.S.C. 3507. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910–0183. The approval expires on April 30, 2009. A copy of the supporting statement for this information collection is available on the Internet at https://www.fda.gov/ ohrms/dockets. Dated: May 4, 2006. Jeffrey Shuren, Assistant Commissioner for Policy. [FR Doc. E6–7157 Filed 5–10–06; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. 2005N–0157] BILLING CODE 4163–18–P Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Adverse Drug Experience Reporting DEPARTMENT OF HEALTH AND HUMAN SERVICES AGENCY: Food and Drug Administration ACTION: [Docket No. 2005N–0425] SUMMARY: The Food and Drug Administration (FDA) is announcing that a collection of information entitled ‘‘Adverse Drug Experience Reporting’’ has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995. FOR FURTHER INFORMATION CONTACT: Karen L. Nelson, Office of Management Programs (HFA–250), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301–827–1482. SUPPLEMENTARY INFORMATION: In the Federal Register of February 7, 2006 (71 FR 6281), the agency announced that the proposed information collection had been submitted to OMB for review and clearance under 44 U.S.C. 3507. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910–0230. The approval expires on April 30, 2009. A copy of the supporting statement for this information collection is available on the Internet at https://www.fda.gov/ ohrms/dockets. Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; General Administrative Procedures: Citizen Petitions; Petition for Reconsideration or Stay of Action; Advisory Opinions AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing that a collection of information entitled ‘‘General Administrative Procedures: Citizen Petitions; Petition for Reconsideration or Stay of Action; Advisory Opinions’’ has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995. FOR FURTHER INFORMATION CONTACT: Jonna Capezzuto, Office of Management Programs (HFA–250), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301–827–4659. SUPPLEMENTARY INFORMATION: In the Federal Register of February 10, 2006 PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 Food and Drug Administration, HHS. E:\FR\FM\11MYN1.SGM Notice. 11MYN1

Agencies

[Federal Register Volume 71, Number 91 (Thursday, May 11, 2006)]
[Notices]
[Page 27502]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-7157]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. 2005N-0425]


Agency Information Collection Activities; Announcement of Office 
of Management and Budget Approval; General Administrative Procedures: 
Citizen Petitions; Petition for Reconsideration or Stay of Action; 
Advisory Opinions

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
collection of information entitled ``General Administrative Procedures: 
Citizen Petitions; Petition for Reconsideration or Stay of Action; 
Advisory Opinions'' has been approved by the Office of Management and 
Budget (OMB) under the Paperwork Reduction Act of 1995.

FOR FURTHER INFORMATION CONTACT: Jonna Capezzuto, Office of Management 
Programs (HFA-250), Food and Drug Administration, 5600 Fishers Lane, 
Rockville, MD 20857, 301-827-4659.

SUPPLEMENTARY INFORMATION: In the Federal Register of February 10, 2006 
(71 FR 7052), the agency announced that the proposed information 
collection had been submitted to OMB for review and clearance under 44 
U.S.C. 3507. An agency may not conduct or sponsor, and a person is not 
required to respond to, a collection of information unless it displays 
a currently valid OMB control number. OMB has now approved the 
information collection and has assigned OMB control number 0910-0183. 
The approval expires on April 30, 2009. A copy of the supporting 
statement for this information collection is available on the Internet 
at https://www.fda.gov/ohrms/dockets.

    Dated: May 4, 2006.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E6-7157 Filed 5-10-06; 8:45 am]
BILLING CODE 4160-01-S

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.